2Usui J, Yamagata K, Kai H, et al. Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Intern Med ,2001,40 : 697 - 702.
3Kanno Y, Okada H, Saruta T et al. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3 - year follow - up. Clin Nephrol, 2000,54: 360 - 365.
4Kanno Y, Okada H, Yamaji Y, et al. Angiotensin - converting - enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation. QJM, 2005 , 98 ( 3 ) : 199 - 203.
5Li PK,Leung CB, Chow KM,et al. Hong Kong study using valsartan in IgA nephropathy (HKVIN) : a double - blind, randomized, placebo - controlled study. Am J Kidney Dis,2006,47 ( 5 ) .-751 - 60.
6Russo D, Pisani A, Balletta MM et al. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis, 1999,33:851 -856.
7Nakao N, Yoshimura A, Morita H et al. Combination treatment of angiotensin - Ⅱ receptor blocker and angiotensin - converting - enzyme inhibitor in non - diabetic renal disease ( COOPERATE ) : a randomized controlled trial. Lancet,2003,361 : 117 - 124.
8Dillon JJ. Angiotensin - converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy. Semin Nephrol,2004,24 ( 3 ) : 218 -224.
9MacKinnon M, Shurraw S, Akbari A, et al. Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease : a systematic review of the efficacy and safety data. Am J Kidney Dis,2006,48( 1 ) :8 -20.
10Pozzi C, Vecchio LD, Casartelli D, et al. ACE inhibitors and angio- tensin Ⅱ receptor blockers in IgA nephropathy with mild proteinuria : the ACEARB study. J Nehrol,2006,19 : 508 - 514.
